Newborn Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Technology, By Test Type, By End User, By Region and Competition, 2020-2030F

Description

The Global Newborn Screening Market was valued at USD 854.15 million in 2024 and is projected to reach USD 1345.11 million by 2030, growing at a CAGR of 7.86% during the forecast period. This market encompasses the early detection and diagnosis of genetic, metabolic, and congenital conditions in newborns, typically within the first days after birth. As congenital disorders continue to account for a significant share of infant morbidity and mortality globally, newborn screening has become a vital component of public healthcare systems. Increased government initiatives, advancements in screening technologies, and rising awareness regarding early disease detection have significantly boosted adoption rates. Countries are expanding their newborn screening panels to include a broader array of conditions, while innovations such as next-generation sequencing and tandem mass spectrometry have improved diagnostic accuracy and efficiency. The growing prevalence of congenital conditions, particularly in developing regions, is expected to sustain market growth, supported by private testing initiatives, increased healthcare spending, and global collaborations to standardize screening practices.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 854.15 Million
Market Size 2030	USD 1345.11 Million
CAGR 2025-2030	7.86%
Fastest Growing Segment	Hospitals
Largest Market	North America

Key Market Drivers

Advancements in Technology

Technological innovations have transformed newborn screening, enabling earlier and more precise detection of a wide array of conditions. Next-Generation Sequencing (NGS) facilitates simultaneous analysis of multiple genes, significantly expanding screening capabilities. It has become instrumental in identifying rare and complex genetic conditions with high accuracy. Similarly, Tandem Mass Spectrometry (MS/MS) has revolutionized metabolic screening by allowing multiple analytes to be tested from a single sample, enabling detection of amino acid and fatty acid disorders efficiently. Multiplex assays and enhanced dried blood spot (DBS) technologies have also contributed to the broader and faster adoption of screening for lysosomal storage and immunodeficiency disorders. These technological advancements have reduced false positives, improved patient outcomes, and lowered healthcare costs through early interventions.

Key Market Challenges

Education and Awareness

Despite technological progress, limited public and professional awareness about the significance of newborn screening remains a substantial barrier. Many parents may lack understanding of the benefits and procedures involved, leading to hesitation or refusal of screening. Inconsistent training and knowledge dissemination among healthcare professionals can further impair effective communication with families. Cultural and language differences, especially in diverse or low-resource regions, exacerbate the issue, hindering outreach and engagement. Additionally, varying policies and resource availability across countries contribute to disparities in screening coverage and effectiveness. Efforts to improve education, standardize procedures, and address misinformation are crucial to increasing participation and acceptance globally.

Key Market Trends

Rise in Private Testing

There is a growing trend toward private newborn screening services, as parents increasingly seek broader testing panels than those offered by public health programs. Personalized medicine, rapid result delivery, and advanced technologies are driving demand for private services. These centers offer greater autonomy and confidentiality, along with supplemental services like genetic counseling and family health planning. In regions with limited or inconsistent public programs, private testing ensures continued access to comprehensive screening. Additionally, private providers often serve mobile populations seeking continuity of care across borders. As awareness grows and disposable incomes rise, private newborn screening is expected to gain further traction, especially in urban and high-income segments.

Key Market Players

Bio-Rad Laboratories Inc.
GE Healthcare
Masimo Corporation
Medtronic Inc.
Natus Medical Incorporated
PerkinElmer Inc.
Trivitron Healthcare
ZenTech SA
Demant A/S
Hill-Rom Holdings Inc.

Report Scope

In this report, the Global Newborn Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Newborn Screening Market, By Technology:

Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assays
DNA Assays
Other Technologies

Newborn Screening Market, By Test Type:

Dried Blood Spot
Hearing Screening
Critical Congenital Heart Defect (CCHD)
Other Test Types

Newborn Screening Market, By End User:

Hospitals
Diagnostic Centers
Other End Users

Newborn Screening Market, By Region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Newborn Screening Market.

Available Customizations

Global Newborn Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Newborn Screening Market

5. Voice of Customer

6. Global Newborn Screening Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies)
- 6.2.2. By Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types)
- 6.2.3. By End User (Hospitals, Diagnostic Centers, and Other End Users),
- 6.2.4. By Region
- 6.2.5. By Company (2024)
6.3. Market Map

7. Asia Pacific Newborn Screening Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By Test Type
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Asia Pacific: Country Analysis
- 7.3.1. China Newborn Screening Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Technology
    - 7.3.1.2.2. By Test Type
    - 7.3.1.2.3. By End User
- 7.3.2. India Newborn Screening Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Technology
    - 7.3.2.2.2. By Test Type
    - 7.3.2.2.3. By End User
- 7.3.3. Australia Newborn Screening Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Technology
    - 7.3.3.2.2. By Test Type
    - 7.3.3.2.3. By End User
- 7.3.4. Japan Newborn Screening Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Technology
    - 7.3.4.2.2. By Test Type
    - 7.3.4.2.3. By End User
- 7.3.5. South Korea Newborn Screening Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Technology
    - 7.3.5.2.2. By Test Type
    - 7.3.5.2.3. By End User

8. Europe Newborn Screening Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By Test Type
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Newborn Screening Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Technology
    - 8.3.1.2.2. By Test Type
    - 8.3.1.2.3. By End User
- 8.3.2. Germany Newborn Screening Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Technology
    - 8.3.2.2.2. By Test Type
    - 8.3.2.2.3. By End User
- 8.3.3. Spain Newborn Screening Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Technology
    - 8.3.3.2.2. By Test Type
    - 8.3.3.2.3. By End User
- 8.3.4. Italy Newborn Screening Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Technology
    - 8.3.4.2.2. By Test Type
    - 8.3.4.2.3. By End User
- 8.3.5. United Kingdom Newborn Screening Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Technology
    - 8.3.5.2.2. By Test Type
    - 8.3.5.2.3. By End User

9. North America Newborn Screening Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By Test Type
- 9.2.3. By End User
- 9.2.4. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Newborn Screening Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Technology
    - 9.3.1.2.2. By Test Type
    - 9.3.1.2.3. By End User
- 9.3.2. Mexico Newborn Screening Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Technology
    - 9.3.2.2.2. By Test Type
    - 9.3.2.2.3. By End User
- 9.3.3. Canada Newborn Screening Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Technology
    - 9.3.3.2.2. By Test Type
    - 9.3.3.2.3. By End User

10. South America Newborn Screening Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By Test Type
- 10.2.3. By End User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Newborn Screening Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Technology
    - 10.3.1.2.2. By Test Type
    - 10.3.1.2.3. By End User
- 10.3.2. Argentina Newborn Screening Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Technology
    - 10.3.2.2.2. By Test Type
    - 10.3.2.2.3. By End User
- 10.3.3. Colombia Newborn Screening Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Technology
    - 10.3.3.2.2. By Test Type
    - 10.3.3.2.3. By End User

11. Middle East and Africa Newborn Screening Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Technology
- 11.2.2. By Test Type
- 11.2.3. By End User
- 11.2.4. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Newborn Screening Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Technology
    - 11.3.1.2.2. By Test Type
    - 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Newborn Screening Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Technology
    - 11.3.2.2.2. By Test Type
    - 11.3.2.2.3. By End User
- 11.3.3. UAE Newborn Screening Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Technology
    - 11.3.3.2.2. By Test Type
    - 11.3.3.2.3. By End User

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions

14. Global Newborn Screening Market: SWOT Analysis

15. Porter's Five Forces Analysis

15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

17.1. Bio-Rad Laboratories Inc.
- 17.1.1. Business Overview
- 17.1.2. Company Snapshot
- 17.1.3. Products & Services
- 17.1.4. Financials (As Reported)
- 17.1.5. Recent Developments
- 17.1.6. Key Personnel Details
- 17.1.7. SWOT Analysis
17.2. GE Healthcare
17.3. Masimo Corporation
17.4. Medtronic Inc.
17.5. Natus Medical Incorporated
17.6. PerkinElmer Inc.
17.7. Trivitron Healthcare
17.8. ZenTech SA
17.9. Demant A/S
17.10. Hill-Rom Holdings Inc.